Select Medical (SEM)
(Delayed Data from NYSE)
$27.41 USD
+0.02 (0.07%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $27.43 +0.02 (0.07%) 7:58 PM ET
4-Sell of 5 4
A Value B Growth B Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$27.41 USD
+0.02 (0.07%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $27.43 +0.02 (0.07%) 7:58 PM ET
4-Sell of 5 4
A Value B Growth B Momentum A VGM
Zacks News
Analysts Estimate Select Medical (SEM) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Select Medical (SEM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Weakness Seen in Select Medical Holdings (SEM) Estimates: Should You Stay Away?
by Zacks Equity Research
Select Medical Holdings (SEM) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.
Select Medical (SEM) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Select Medical (SEM) delivered earnings and revenue surprises of 27.78% and 0.12%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Select Medical (SEM) Q3 Earnings Preview: What's Shaping Up?
by Zacks Equity Research
Select Medical (SEM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Select Medical (SEM) Misses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Select Medical (SEM) delivered earnings and revenue surprises of -13.89% and -0.57%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Select Medical (SEM) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Select Medical's (SEM) first-quarter results find support in bottom-line growth, higher revenues and solid segmental performances. However, rise in expenses is a downside.
Will Cigna (CI) Beat Q1 Earnings Estimates This Time Again?
by Zacks Equity Research
Cigna (CI) Q1 earnings to see upside from higher revenues, enrollment growth.
Should Value Investors Pick Select Medical Holdings (SEM) Stock?
by Zacks Equity Research
Select Medical Holdings (SEM) is an inspired choice for value investors, as it is hard to beat its incredible lineup of statistics on this front.
4 Health Care Stocks Set to Beat Earnings Estimates in 4Q
by Zacks Equity Research
This attractive sector has several companies with upside potential.
Mednax (MD) Acquires Urology Unit, Deepens Reach in Florida
by Zacks Equity Research
Mednax (MD) continues with inorganic growth at a time when organic growth seems difficult to achieve.
4 Top Performers From Health Insurance Industry in Q3
by Zacks Equity Research
The Health Insurance industry gains from growing medicare business, benefits of ACA, business diversification and healthy balance sheets.
LifePoint (LPNT) Sells Unit to Focus on High-Growth Markets
by Zacks Equity Research
LifePoint (LPNT) continues its inorganic growth via divestitures and acquisitions.
Zacks Industry Outlook Highlights: Triple-S Management, Anthem, UnitedHealth Group and Select Medical Holdings
by Zacks Equity Research
Zacks Industry Outlook Highlights: Triple-S Management, Anthem, UnitedHealth Group and Select Medical Holdings
Health Insurance Industry Stock Outlook - Sept. 2017
by Zacks Equity Research
Investing in growing health services business, product diversification, instituting changes in an effort to become more consumer-centric, and investments in technology have helped these companies reap hidden opportunities.
Brookdale Senior Living (BKD) Catches Eye: Stock Up 7.5%
by Zacks Equity Research
Brookdale Senior Living Inc. (BKD) was a big mover last session, as the company saw its shares rise nearly 8% on the day.
Centene (CNC) Beats Q1 Earnings on HealthNet Acquisition
by Zacks Equity Research
Centene Inc. (CNC) reported first-quarter 2017 adjusted net income per share of $1.12 cents, which beat the Zacks Consensus Estimate by 5.7%.
Top Ranked Value Stocks to Buy for April 19th
by Zacks Equity Research
Here are four stocks with buy rank and strong value characteristics for investors to consider today, April 19th:
Healthcare Earnings to Watch on Feb 23: ACHC, SEM & More
by Zacks Equity Research
We take a sneak peek at two healthcare stocks scheduled to report fourth-quarter figures on Feb 23.
Can HCA Holdings Retain its Business Strength in 2017?
by Zacks Equity Research
While HCA Holdings (HCA) gave a strong outlook for its top and bottom lines, details on admission in the fourth quarter were not so appealing.
Select Medical Holdings (SEM) Provides Guidance for 2017
by Zacks Equity Research
Select Medical (SEM) recently unveiled its guidance for 2017 and expects earnings per share between 73 cents and 91 cents on revenues of $4.4???$4.6 billion in 2017.